Physician

None

According to 2025 Medicare claims, NPI 1609869650 (NPI: 1609869650) practices family practice in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is IYENGAR HEMATOLOGY ONCOLOGY MEDICAL CENTER PA (NPI: 1053441071) and primary practice location at 07002-4654.

1609869650's data goes back to 2015 and runs through 2024. For example, in 2019, this provider had 29 traditional Medicare patients, billed 127 HCPCS/CPT codes, and received $9,779 in Medicare payments. 2024 Part D data shows 676 prescription claims across 111 beneficiaries totaling $121,144 in drug costs, led by Xifaxan (Rifaximin). 2017 DME data shows 15 claims. Open Payments data shows 21 records totaling $462. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $35,053 to $9,779. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $103,313 and ending at $121,144. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$45K$89K2015 Medicare payment: $35,053 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $89,181 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $25,708 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $36,901 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $9,779 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201551351$35,053
20161264,241$89,181
201753327$25,708
201871598$36,901
201929127$9,779
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$92K$183K2015 Drug cost: $103,313 (USD; Tot_Drug_Cst)2016 Drug cost: $183,286 (USD; Tot_Drug_Cst)2017 Drug cost: $121,611 (USD; Tot_Drug_Cst)2018 Drug cost: $122,223 (USD; Tot_Drug_Cst)2019 Drug cost: $132,948 (USD; Tot_Drug_Cst)2020 Drug cost: $111,039 (USD; Tot_Drug_Cst)2021 Drug cost: $87,216 (USD; Tot_Drug_Cst)2022 Drug cost: $88,528 (USD; Tot_Drug_Cst)2023 Drug cost: $120,191 (USD; Tot_Drug_Cst)2024 Drug cost: $121,144 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015118996$103,313
20161351,078$183,286
2017142982$121,611
20181351,054$122,223
20191261,030$132,948
2020127931$111,039
2021116834$87,216
2022118732$88,528
2023123733$120,191
2024111676$121,144

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.4K$2.8K2015 Medicare payment: $2,825 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,714 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$2,825
2016N/R24$2,230
2017N/R15$1,714
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XifaxanRifaximin12360$36,984
EliquisApixaban421,680$32,846
VemlidyTenofovir Alafenamide13390$18,844
OmeprazoleOmeprazole301,020$297
Pantoprazole SodiumPantoprazole Sodium161,140$284

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$462Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for NPI 1609869650?

Tedicare shows public-source Medicare data for NPI 1609869650 (NPI 1609869650), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does NPI 1609869650 have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to NPI 1609869650?

NPI 1609869650 is linked to IYENGAR HEMATOLOGY ONCOLOGY MEDICAL CENTER PA (billing NPI 1053441071) in the available physician profile data.

Does NPI 1609869650 have Open Payments data?

NPI 1609869650 has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.